| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/31/2008 | US20080182994 Crystallization from solvent; removal of impurities |
| 07/31/2008 | US20080182893 Prevention, therapy atherosclerosis; prevent plaque destabilization; using ienzyme modified soquercitrin |
| 07/31/2008 | US20080182888 Novel Crystalline Compounds |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182873 Process for the manufacture of hmg-coa reductase inhibitors |
| 07/31/2008 | US20080182864 2-(1-Aroylaminoalkyl)-3-(alkylaryl)-7-(halo- or cyano)quinazolinone derivatives, e.g., 2-[1'-(N,N-dimethylethylenediamino)propyl]-3-benzylquinazolin-4-one; mitotic kinesin spindle protein inhibitors; disrupting mitosis; modulating mitotic spindle formation; restenosis |
| 07/31/2008 | US20080182860 Pyrimidine Compounds as Purine Receptor Antagonist |
| 07/31/2008 | US20080182859 Small organic molecule regulators of cell proliferation |
| 07/31/2008 | US20080182858 infectious disorders; antiarrhythmic, antifibrillatory agents; 1-[[[5-(4-chlorophenyl)-2-furanyl]methylene]amino]-3-[4-(4-methyl-1-piperazinyl)butyl]-2,4-imidazolidinedione dihydrochloride; different polymorphic, hydrate and solvate forms of compound are advantageous for the manufacture of compositions |
| 07/31/2008 | US20080182853 suppressing neuronal death; sudden loss of oxygen and/or energy loss, and degenerative diseases, such as Alzheimer's disease; Parkinson's disease; ischemic states |
| 07/31/2008 | US20080182832 orphan nuclear Receptor agonists; chenodeoxycholic acid, ursodeoxycholic acid or cholic acid derivatives; atherosclerosis, arteriosclerosis, dyslipidemia, hypercholesterolemia, and hypertriglyceridemia.atherosclerosis, arteriosclerosis, hypercholestremia, and hyperlipidemia |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182828 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen and a progestogen equivalent to 90 mu g per day of norgestimate; hot flushes |
| 07/31/2008 | US20080182820 Mixtures of sulfated oligosaccharides |
| 07/31/2008 | US20080182811 Activating a metabotropic glutamate receptor by administering one or more kinds of amino acids selected from amino acids other than glutamic acid; use in treating neurological diseases, cardiovascular diseases, surgical diseases, neurosurgical diseases, thoracic surgical diseases, orthopedic diseases |
| 07/31/2008 | US20080182797 Short peptides comprising the amino acid sequence Cys-Glu-Phe-His as well as analogs and derivatives thereof, which peptides efficiently denitrate cellular proteins and thus prevent tissue damage associated with excess nitric oxide and its reactive species; protection against ischemia/reperfusion injury |
| 07/31/2008 | US20080182791 Medicament for Improving Prognostic Survival in Therapy of Malignant Tumor |
| 07/31/2008 | US20080182787 Protein isolated from plants (Moringa) or synthesized by recombinant DNA technology; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 07/31/2008 | US20080182785 Protracted Glp-1 Compounds |
| 07/31/2008 | US20080182779 Apelin and uses thereof |
| 07/31/2008 | US20080182292 Investigation of new membrane tubes containing F-actin and myosin of a diameter of 50-400 nm and <50+ micrometers length which span the cells; spreading, incubating and staining with a detectable microscopic stain, fluorescent dye, to obtain stained plasma membranes for 3-D cell microscopy |
| 07/31/2008 | US20080181966 Modafinil pharmaceutical compositions |
| 07/31/2008 | US20080181960 Solid dispersion of completely amorphous carotenoids; polyvinylpyrrolidone, hydroxypropylcellulose hydroxypropylmethylcellulose solubility-enhancing polymers;spray dried powder increased bulk density; substantially free of lipids and oils |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | US20080181928 stent; coating comprising a dry film comprising at least one lipid bilayer and at least one pharmaceutically effective agent; Upon exposure to an aqueous fluid, liposomes are released |
| 07/31/2008 | US20080181927 Device for local and/or regional delivery employing liquid formulations of therapeutic agents |
| 07/31/2008 | US20080181903 Urodilatin; immunoglobulins; fusion proteins; pharmacokinetics |
| 07/31/2008 | US20080181879 Fibrin gel for controlled release of tgf-beta and uses thereof |
| 07/31/2008 | US20080181878 composition of thrombin and fibrinogen dimer selected from the group consisting of fibrinogen gamma A/ gamma ' heterodimer and fibrinogen gamma '/ gamma ' homodimer; trauma, plastic, dental, and general surgery, minimally invasive surgery, endoscopy, and microsurgery |
| 07/31/2008 | US20080181871 Focal calcium channel modulation |
| 07/31/2008 | CA2676208A1 Compound, a1 adrenergic receptor antagonist agent, and composition |
| 07/31/2008 | CA2675538A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 07/31/2008 | CA2674717A1 Use of d-ribose to treat cardiac arrhythmias |
| 07/30/2008 | EP1950300A2 Antibody variants with higher binding affinity compared to parent antibodies |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950209A1 Agent for treatment of circulatory failure |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1949937A1 Lipoxin analogs as novel inhibitors of restenosis |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949904A2 Cell therapy for chronic stroke |
| 07/30/2008 | EP1949901A2 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/30/2008 | EP1949893A2 Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors |
| 07/30/2008 | EP1948818A2 Use of b cell expansion agents in generating antibodies |
| 07/30/2008 | EP1948661A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/30/2008 | EP1948654A1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 07/30/2008 | EP1948641A1 An improved process for preparation of irbesartan |
| 07/30/2008 | EP1948636A2 Compounds and compositions as lxr modulators |
| 07/30/2008 | EP1948623A2 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/30/2008 | EP1948246A2 Stem cell factor therapy for tissue injury |
| 07/30/2008 | EP1948224A1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 07/30/2008 | EP1948220A2 Methods of decreasing vascular calcification using il-1 inhibitors |
| 07/30/2008 | EP1948215A1 Inhibitors of parp activity and uses thereof |
| 07/30/2008 | EP1948210A1 Method of treatment for ischemic heart disease |
| 07/30/2008 | EP1948189A1 Use of aza-phenylalanine compounds for treating cardiac arrhythmia |
| 07/30/2008 | EP1948183A1 Compositions for the treatment and prevention of heart disease and methods of using same |
| 07/30/2008 | EP1948158A1 Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 07/30/2008 | EP1948155A2 Pharmaceutical compositions comprising droxidopa |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1480646B1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 07/30/2008 | EP1064009B2 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects |
| 07/30/2008 | EP1059927B1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity |
| 07/30/2008 | EP1054881B1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/30/2008 | EP0968713B1 Plasters containing isosorbide nitrate |
| 07/30/2008 | CN101233225A Strain of turkey tail mushroom, extract from the same, and use of the same |
| 07/30/2008 | CN101233110A Substance with oxidation resistance, agedness protection and anti-ischemia active and preparing method thereof |
| 07/30/2008 | CN101233106A Thiomorpholine compound and process for preparing the same |
| 07/30/2008 | CN101232901A Joint use of sulfonamide based compound with angiogenesis inhibitor |
| 07/30/2008 | CN101232897A Angiogenetic agent containing adrenomedulin as the active ingredient |
| 07/30/2008 | CN101230090A Blood peptide X and derivative thereof as well as preparation method and use thereof |
| 07/30/2008 | CN101230060A Substitutional piperidines |
| 07/30/2008 | CN101230035A Aspartic acid amlodipine series salt as well as preparation method, composition, preparation and tablets thereof |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN101229377A Coordinated use method of trinosin magnesium chloride and sodium chloride injecta |
| 07/30/2008 | CN101229376A Medicine compounds containing isosorbide mononitrate for treating high blood pressure |
| 07/30/2008 | CN101229375A Medicine compounds containing isosorbide mononitrate for treating high blood pressure |
| 07/30/2008 | CN101229369A Antiatheroscloresis thrombolytic soft capsule and preparing method thereof |
| 07/30/2008 | CN101229363A Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 07/30/2008 | CN101229354A Medicine for treating cerebral thrombosis and preparing method thereof |
| 07/30/2008 | CN101229344A Chinese traditional medicine composite for treating heart disease and preparing method thereof |
| 07/30/2008 | CN101229341A Medicine rapid healing hypertension merging hemiplegy |
| 07/30/2008 | CN101229328A Method of extracting eucalyptus and bamboo wood flavonoid |
| 07/30/2008 | CN101229314A Chinese traditional medicine preparation for treating myocardial infarction induced by myocardial ischemia |
| 07/30/2008 | CN101229312A Medicine compounds capable of regulating hypertension, hyperlipemia and angina |
| 07/30/2008 | CN101229297A Chinese herbal medicine cool tea for treating inside and outside mixed hemorrhoid |
| 07/30/2008 | CN101229296A Medicine compounds for treating hypertension, heart disease and angina |
| 07/30/2008 | CN101229286A Compounds of vitamin and plant extract |
| 07/30/2008 | CN101229274A Pharmaceutical composition for preventing or treating impotence induced hyperlipidemia and/or hypertension |
| 07/30/2008 | CN101229268A Retinervus-smoothing regeneration ointment |
| 07/30/2008 | CN101229267A Medicine compounds for pulmonary and rheumatic heart disease and preparing method thereof |
| 07/30/2008 | CN101229264A Chinese traditional medicine prescription and preparation of active ingredient thereof |
| 07/30/2008 | CN101229257A External demibain therapy hip bath preparation for curing tertiary haemorrhoids anal external incarceration restoration |
| 07/30/2008 | CN101229254A Chinese traditional medicine preparation for treating cerebral apoplexy without sequelae |
| 07/30/2008 | CN101229252A Agrimony total flavone extract, preparing method and applications thereof |
| 07/30/2008 | CN101229241A Application of Chinese traditional medicine compounds on preparing medicines promoting mesenchymal stem cells surviving in the body and cardioblast differentiation |